A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2004
10/20/2004	EP1467718A1 Method of treatment of a patient requiring analgesia
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1467695A2 Hiv integrase inhibitors
10/20/2004	EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
10/20/2004	EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors
10/20/2004	EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004	EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators
10/20/2004	EP1263725B1 Novel compounds
10/20/2004	EP1246619B1 Urotensin-ii receptor antagonists
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/20/2004	EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004	EP1194115B1 Topically applied idebenone-containing agent with protective and regenerative effect
10/20/2004	EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/20/2004	EP1151008B1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/20/2004	EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004	EP1135112B1 An oral formulation for gastrointestinal drug delivery
10/20/2004	EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
10/20/2004	EP1073440B1 sPLA 2 INHIBITOR ESTERS
10/20/2004	EP1043028B1 Phytase for preventing or treating mastitis
10/20/2004	EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis
10/20/2004	EP0904107B1 Immunoglobin-like domains with increased half lives
10/20/2004	EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004	EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments
10/20/2004	EP0850062B1 Use of halofuginone for the preparation of a medicament for attenuating neovascularization and for treating human malignant tumours
10/20/2004	EP0830136B1 New cryptophycins from synthesis
10/20/2004	CN1539012A Electrodes coated with treating agent and uses thereof
10/20/2004	CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004	CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them
10/20/2004	CN1538959A Fused-polycyclic compounds
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004	CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004	CN1538853A T cell regulatory genes and methods of use thereof
10/20/2004	CN1538850A BMP Binding proteins for use in bone or cartilage regenearation
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538847A 4-amino-6-phenyl-pyrrolo [2,3-D] pyrimidine derivatives
10/20/2004	CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use
10/20/2004	CN1538842A Atineoplastic combinations
10/20/2004	CN1538839A Swine growth promoters and method of promoting swine growth
10/20/2004	CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004	CN1538836A Substituted amine derivatives and method of use
10/20/2004	CN1538812A Body temp-raising agent of amino acidds for eating or drinking and for medical use
10/20/2004	CN1537857A Compound, its preparation method and its application
10/20/2004	CN1537856A Anti-first-pass effect compounds
10/20/2004	CN1537533A Method for preparing medicine of levo-stephandinine
10/20/2004	CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/20/2004	CN1171888C Substituted purin derivatives, preparation method and use
10/20/2004	CN1171887C Respiratory syncytial virus replication inhibitors
10/20/2004	CN1171870C Inhibitors of cysteine protease
10/20/2004	CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors
10/20/2004	CN1171618C Healthy medicinal spirit for tonifying kidney and strengthening Yang
10/20/2004	CN1171589C Urease inhibitors
10/20/2004	CN1171586C Pharmaceutical compositions comprising monoamine oxidase B inhibitors
10/19/2004	US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004	US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders
10/19/2004	US6806312 Thermoplastic resin composition
10/19/2004	US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004	US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
10/19/2004	US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists
10/19/2004	US6806274 Quinazoline derivatives
10/19/2004	US6806266 Staurosporin derivatives
10/19/2004	US6806265 For therapy and prophylaxis of hiv infection
10/19/2004	US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004	US6806255 Compounds and methods for modulating adhesion molecule function
10/19/2004	US6806070 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents
10/19/2004	US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers
10/19/2004	US6805878 Transdermal administration of ACE inhibitors
10/19/2004	US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004	US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/19/2004	CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/19/2004	CA2155796C 2,3-dihydro-1h-isoindole derivatives, a process for their preparation and their use as serotonin reuptake inhibitors
10/18/2004	CA2464961A1 Polymorphous forms of rosiglitazone maleate
10/14/2004	WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/14/2004	WO2004087763A1 Modified antibody against cd22 and utilization thereof
10/14/2004	WO2004087762A1 Antibodies inhibiting tansportation activity of peptide transporter
10/14/2004	WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
10/14/2004	WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004	WO2004087656A1 Conjugates of 2,4-ethano-bridged and 2,4-propano-bridged 3,6,9-triaza-nonanoic acid, 3n,6n,9,9n-tetraethanoic acid, and corresponding phosphoric acid methylene derivatives and the substitution products thereof with biomolecules, methods for the production thereof, and the use of the same for produ
10/14/2004	WO2004087208A1 Thermotherapeutic for malignant tumor comprising heat shock protein and fine magnetic particles
10/14/2004	WO2004087162A1 Uses of tryprostatin for the reversal of cancer drug resistance
10/14/2004	WO2004087125A1 Amino acid derivatives as inhibitors of mammalian sodium channels
10/14/2004	WO2004086880A1 Sodium chloride-containing foods and drinks
10/14/2004	WO2004041245B1 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases
10/14/2004	WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
10/14/2004	WO2004005256A3 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors
10/14/2004	WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators
10/14/2004	WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004	WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004	WO2003101395A3 Formulations for amylin agonist peptides
10/14/2004	US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen
10/14/2004	US20040204590 Ep4 receptor agonist, compositions and methods thereof
10/14/2004	US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones
10/14/2004	US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004	US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/14/2004	US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
10/14/2004	US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction
10/14/2004	US20040204487 Novel medicinal product

1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 1564